Citations

1. Griffin JW (2004). Guillain-Barré syndrome (acute inflammatory demyelinating polyneuropathy) section of Peripheral neuropathies: Immune-mediated neuropathies. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., vol 2., chap. 462, pp. 2379–2387. Philadelphia: Saunders.

2. Gilroy J (2000). Guillain-Barré syndrome (acute inflammatory demyelinating polyneuropathy). In Basic Neurology, 3rd ed., pp. 612–614. New York: McGraw-Hill.

3. Centers for Disease Control and Prevention (2006). Inactivated influenza vaccine: What you need to know. Vaccine Information Statement. Department of Health and Human Services, National Immunization Program (6/30/06). Available online: http://www.cdc.gov/nip/publications/VIS/vis-flu.pdf.

4. Vajsar J, et al. (2003). Long-term outcome in children with Guillain-Barré syndrome. Journal of Pediatrics, 142: 305–309.

5. Hughes RAC, et al. (2003). Practice parameter: Immunotherapy for Guillain-Barré syndrome. Neurology, 61: 736–740.

6. Chiò A, et al. (2003). Guillain-Barré syndrome: A prospective, population-based incidence and outcome survey. Neurology, 60(7): 1146–1150.

7. Victor M, Ropper AH (2001). Guillain-Barre syndrome section of Diseases of the spinal cord, peripheral nerve, and muscle. In Adams and Victor's Principles of Neurology, 7th ed., pp. 1380–1387. New York: McGraw-Hill.

Other Works Consulted

• Brannagan TH, et al. (2005). Acquired neuropathies. In LP Rowland, ed., Merritt's Neurology, 11th ed., pp. 748–767. Philadelphia: Lippincott Williams and Wilkins.

• Hughes RAC, et al. (2005). Intravenous immunoglobulin for Guillain-Barre Syndrome. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

• Lovitt S, Harati Y (2003). Guillaine-Barré syndrome. In RW Evans, ed., Saunders Manual of Neurologic Practice, chap. 2, pp. 572–575. Philadelphia: Saunders.

• Raphael JC, et al. (2005). Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.